Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial - Concepedia

Concepedia

Publication | Open Access

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

DOI Full Paper Access

192

Citations

36

References

2020

Year

Tom P. Freeman, Chandni Hindocha, Gianluca Baio, Natacha D. C. Shaban, Emily M Thomas, Danica Astbury, Abigail M. Freeman, Rachel Lees, Sam Craft, Paul D. Morrison,

The Lancet Psychiatry

Adaptive Bayesian TrialCannabis UsePsychoactive DrugSubstance UseCannabinoidsPsychiatryHealth SciencesAddictionAddiction TreatmentPharmacologyAddiction MedicinePhase 2AMedicineCannabinoid PharmacologyCannabis Use DisorderSubstance Use DisordersCannabis

References

	Year	Citations

Page 1

Page 1